INTERNATIONAL PATENT: HINOVA PHARMACEUTICALS INC., 海创药业股份有限公司 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS"

Posted On: 2026-04-13

GENEVA, April 13 -- HINOVA PHARMACEUTICALS INC. (No.2-3, 4th Floor, RongYao Tower 1, 5 South Keyuan Road, High-tech ZoneChengdu, Sichuan 610041), 海创药业股份有限公司 (中国四川省成都市高新区科园南路5号蓉药大厦1栋4层附2、3号) filed a patent application (PCT/CN2025/125966) for "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS" on Sep 30, 2025. With publication no. WO/2026/073512, the details related to the pa...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: HINOVA PHARMACEUTICALS INC., 海创药业股份有限公司 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS"